Gabriella Horváth

Dr. Gabriella Horváth


Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2010 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
Gabriella HorváthGabriella Horváth
Gabriella Horváth
RBReka Brubel
Reka Brubel
KKKrisztina Kovacs
Krisztina Kovacs
DRDora Reglodi
Dora Reglodi
BOBalazs Opper
Balazs Opper
BRBoglarka Racz
Boglarka Racz

Verified
Journal Article
Open access
PDF file
Gabriella HorváthGabriella Horváth
Gabriella Horváth
BOBalazs Opper
Balazs Opper
DRDora Reglodi
Dora Reglodi
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic neuropeptide with a widespread distribution throughout the entire body including the urinary system. PACAP exerts protective actions in different injury models related to several organ systems. Its protective effect is mainly based on its antiapoptotic, anti-inflammatory and antioxidant effects. The present review aims to summarize the effects of PACAP in pathologies associated with inflammation and oxidative stress-induced damage in the kidney. Both in vitro and in vivo data are available proving its protective actions against oxidative stress, hypoxia, renal ischemia/reperfusion, diabetic nephropathy, myeloma kidney injury, amyloidosis and different types of drug-induced nephropathies. Data showing the nephroprotection by PACAP emphasize the potential of PACAP’s therapeutic use in various renal pathologies.

16 March 2010 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
Gabriella HorváthGabriella Horváth
Gabriella Horváth
BRBoglarka Racz
Boglarka Racz
DRDora Reglodi
Dora Reglodi
KKKrisztina Kovacs
Krisztina Kovacs
PKPeter Kiss
Peter Kiss
PSPeter Szakaly
Peter Szakaly

16 November 2018 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
ELEszter Laszlo
Eszter Laszlo
TJTamas Juhasz
Tamas Juhasz
AVAdam Varga
Adam Varga
BCBernadett Czibere
Bernadett Czibere
KKKrisztina Kovacs
Krisztina Kovacs
DRDora Reglodi
Dora Reglodi

1 July 2010 in Transplantation Proceedings
Verified
Journal Article
Closed access
Gabriella HorváthGabriella Horváth
Gabriella Horváth
BRB. Racz
B. Racz
PSP. Szakaly
P. Szakaly
PKP. Kiss
P. Kiss
ELE. Laszlo
E. Laszlo
DRD. Reglodi
D. Reglodi

Verified
Journal Article
Open access
PDF file
VSVince Szegeczki
Vince Szegeczki
Gabriella HorváthGabriella Horváth
Gabriella Horváth
HPHelga Perényi
Helga Perényi
Andrea TamasAndrea Tamas
Andrea Tamas
Zsolt RadakZsolt Radak
Zsolt Radak
JTJuhasz Tamas
Juhasz Tamas
Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide with protective functions in the central nervous system and various peripheral organs. PACAP has the highest expression level in the testes, among the peripheral organs, and has a positive regulative role in spermatogenesis and in sperm motility. In the present study, we explored testicular degenerative alterations in a mouse model of Alzheimer’s disease (AD) (B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J) and demonstrated changes in PACAP-regulated signaling pathways. In addition, the effects of increased physical activity of AD (trained AD (TAD)) mice on testis were also followed. Reduced cell number and decreased thickness of basement membrane were detected in AD samples. These changes were compensated by physical activity. Expression of PACAP receptors and canonical signaling elements such as PKA, P-PKA, PP2A significantly decreased in AD mice, and altered Sox transcription factor expression was also detected. Via this signaling mechanism, physical activity compensated the negative effects of AD on the expression of type IV collagen. Our findings suggest that the testes of AD mice can be a good model of testis degeneration. Moreover, it can be an appropriate organ to follow the effects of various interventions such as physical activity on tissue regeneration and signaling alterations.